PD-1 Antibody and Sapropterin Dihydrochloride in Patients With PDAC
NCT06396637
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Adenocarcinoma Metastatic
Interventions
DRUG:
Sapropterin Dihydrochloride
Sponsor
Sun Yat-sen University
Collaborators
[object Object]